While therapies continue to improve, prevention remains the strongest line of defense. Stopping smoking dramatically lowers ...

Wendy Brooks, a patient with extensive-stage small cell lung cancer, and her husband and care partner, Larry Brooks, sat down ...

The third generation EGFR TKI targets EGFR mutant NSCLC, showing improved progression free survival and fewer adverse events ...

Sevabertinib showed promise in early trials for non-squamous non-small-cell lung cancer with HER2 mutations. Read more at ...

Lung cancer battle robotic bronchoscopy improves early diagnosis and treatment access through community lung nodule programs, reducing mortality.

The technology allows medics to reach small spots on the lungs that would usually be left to be monitored, speeding up ...

The 52-year-old from Campbellsville was diagnosed with small cell lung cancer that had already spread to her brain. She was ...

Older Americans with metastatic breast, colorectal, lung, or prostate cancer are spending an increasing amount of time in the ...

Mucommune, a Morrisville-based biotechnology company with roots at the University of North Carolina at Chapel Hill, has been ...

Retevmo (selpercatinib) is a medicine that is used in adults for certain types of non-small-cell lung cancer (NSCLC) that have a certain fusion in a gene known as receptor tyrosine kinase (RET). This ...

The author cherishes family time during Thanksgiving and Christmas, despite undergoing cancer treatment. Chemotherapy and ...

Experts describe the method as a ”paradigm shift” in lung cancer treatment, aiming to significantly reduce anxious waiting ...